Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Plans for primate study of BrainStorm's Parkinson's disease stem cell therapy

Sep. 15, 2006

Tripos and CeNeS extend COMT inhibitor research agreement

Sep. 15, 2006

Enrollment under way in phase IIa safety study of NTx-265 in stroke

Sep. 15, 2006

Preliminary results from phase III study of CIP-Tramadol ER

Sep. 15, 2006

KKJA-0036: novel T-type calcium channel blocker is effective against visceral pain

Sep. 15, 2006

Recent Allergan and ACADIA patents report novel analgesic agents

Sep. 14, 2006

CepTor files IND complete response to move Myodur into clinic

Sep. 14, 2006

New water-soluble cannabinoid CB1 receptor agonists described by Organon

Sep. 13, 2006

Novel orally active CCR1 antagonist for inflammatory disorders from Berlex

Sep. 13, 2006

Cortex submits complete response to lift clinical hold on CX-717

Sep. 13, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...